Get Involved, Participate in Research: Healthy Control Recruitment Join Us in Advancing Medical Knowledge and Improving Health Outcomes for Sepsis Patients Our research studies are essential for developing new treatments and therapies that can improve health outcomes for sepsis patients. We are currently seeking healthy control participants to…
Dec. 15, 2023 Study: Immune system markers may be key for early detection, prognosis prediction in sepsis Media contact: Matt Walker at (352) 265-8395 or mwal0013@shands.ufl.edu By Dorothy Hagmajer GAINESVILLE, Fla. — Sepsis arrives silently. A body’s infection-response gone wrong, the condition’s early symptoms include subtle harbingers like…
Dr. Jennifer Munley’s paper “Non-Selective Beta Blockade Enhances Gut Microbiome Diversity in a Rodent Model of Trauma, Hemorrhage and Chronic Stress” has been selected to advance in the American College of Surgeons (ACS) Committee on Trauma Resident and Fellow Trauma Paper Competition as Basic Science for an oral presentation representing…
Dr. Rincon & team discussing immunological endotypes, secondary to maladaptive reprioritization of myelopoiesis & activation of myeloid cells in severe sepsis survivors.
Congratulations, to the Arizona State University (ASU) senior capstone team on presenting their project, “inSEPStigator: A Rapid Noninvasive Point of Care Device for Sepsis Analysis via Biomarkers” at the ASU Fall Symposium. Their project aims to minimize sepsis complications by providing an affordable device that will successfully quantify sepsis risk…
In a medical field like critical care, where time can mean life or death, a sepsis diagnosis is like the final buzzer. Each year, according to the Centers for Disease Control and Prevention, at least 1.7 million adults in the U.S. develop the condition. Sepsis, the body’s exaggerated…
Specifically, these patients can progress to a condition marked by chronic inflammation and muscle wasting, known as persistent inflammation, immunosuppression and catabolism syndrome, or PICS.
University of Florida researchers are part of a nationwide clinical trial to evaluate whether an anti-cancer medication can be effective against sepsis and septic shock.
Philip Efron, M.D., FACS, FCCM Philip Efron, M.D., FACS, FCCM, an associate professor of surgery and anesthesiology in the University of Florida College of Medicine, has been appointed to the Surgery, Anesthesiology and Trauma Study Section, Center for Scientific Review at the National Institutes of Health, or…
Julie Stortz, M.D. Julie Stortz, M.D., a fourth-year resident with the UF department of surgery, received the New Investigator Award from the Shock Society.
